Accordingly, breast cancers are classified as tumors expressing estrogen receptor-α (ERα/ESR1), progesterone receptor (PGR) and/or epidermal growth factor (EGF) family receptor HER2/ERBB2, which emanate from luminal epithelial progenitors and are classified as luminal-A or -B. This evidence concerns the gene PGR and breast carcinoma.